Christine Ring, Chief Legal Officer at Nurix Therapeutics, sold NRIX on Oct 2, 2026

Data as of Oct 16

▼ SELL$134K5,786 shares at $23.19Christine Ring Chief Legal OfficerNRIX Nurix Therapeutics, Inc.

Watch NRIX

Traded: Oct 2, 2026
Disclosed: Oct 2, 2026
Filed: The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

NRIXSimilar stocks (XLV — its sector index fund), rebased to NRIX's price on the disclosure day

NRIX since disclosure

+6.2%

after the sale

Similar stocks (XLV) since disclosure

+6.3%

XLV — its sector index fund

Change in closing price from Oct 2, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on NRIX →